Kyntra Bio, Inc. (KYNB)
6.99
+0.05
(+0.72%)
USD |
NASDAQ |
May 22, 16:00
6.98
-0.01
(-0.14%)
After-Hours: 20:00
Kyntra Bio Shareholders Equity (Quarterly) : -43.80M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anixa Biosciences, Inc. | 15.08M |
| GT Biopharma, Inc. | 7.58M |
| Perspective Therapeutics, Inc. | 347.44M |
| XOMA Royalty Corp. | 112.90M |
| Gossamer Bio, Inc. | -161.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.63M |
| Total Liabilities (Quarterly) | 118.92M |
| Debt to Equity Ratio | -0.4394 |
| Current Ratio | 3.605 |
| Net Debt Paydown Yield | 51.79% |